With a market capitalization (market cap) of $2.04B — a measure of how much the company is worth — Biohaven Ltd. is the 2098th most valuable company in Healthcare as of August 18, 2026. Shares trade at $13.57, down +6.15% on the day.
of 2,587
price ÷ annual EPS
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
FY 2025
Biohaven Ltd. operates as a biopharmaceutical firm actively engaged in clinical trials. Its primary objective is to advance innovative treatments for disorders affecting the nervous and immune systems, with the potential to transform current medical interventions.
Visit websiteAs of August 18, 2026, Biohaven Ltd. (BHVN) is worth $2.04B — this is its market capitalization, the total value of all its outstanding shares.
Biohaven Ltd.’s market cap is $2.04B, which ranks it #2098 among the most valuable companies in the Healthcare sector tracked on MarketCapLens.
Biohaven Ltd. (BHVN) shares trade at $13.57, down 6.15% on the day, as of August 18, 2026.
Fundamentals are annual. Figures labeled with their fiscal year.
FY 2025